Softwr

Healthcare · head to head

Annalise.ai vs RXNT

Annalise.ai logo

Annalise.ai

Healthcare

Multi-finding chest X-ray and head CT triage AI with FDA clearance on named findings, not on the whole model

From
On request
Rated
-
RXNT logo

RXNT

Healthcare

Cloud practice management and EHR software with a la carte modules

From
On request
Rated
-

The short version

  • Each has a real cost: Annalise.ai the United States cleared indication covers roughly ten findings for triage and notification, far fewer than the model reports, so a buyer who evaluates the full multi-finding output and then contracts in the United States gets a much narrower cleared use.; RXNT specific pricing tiers not displayed; plans reference starting at $118/month
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Annalise.ai and RXNT actually diverge.

Attributes where Annalise.ai and RXNT differ
AttributeAnnalise.aiRXNT
Pricing modelquotesubscription
PlatformsWeb, Cloud, On-premiseWeb

Identical on both: starting price (On request), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Annalise.ai

  • Annalise Enterprise CXR
  • Annalise Enterprise CTB
  • Triage and notification
  • Worklist reprioritisation
  • Localisation overlays
  • Confidence output
  • PACS-native deployment
  • On-premise or cloud inference

Only in RXNT

Nothing recorded that Annalise.ai does not also cover.

What people use each for

The jobs each tool is most often brought in to do.

Annalise.ai

  • An emergency department wanting pneumothorax and intracranial haemorrhage pushed to the front of the reading queue overnight when cover is thinnestnot RXNT
  • A teleradiology provider covering many small hospitals that needs consistent triage before a human readsnot RXNT
  • A screening programme in Europe where the broader CE marked decision support indication, rather than the narrow United States triage clearance, is what is being deployednot RXNT
  • A radiology department building an AI governance programme that wants one vendor covering both chest radiograph and head CT rather than contracting two separate algorithm suppliersnot RXNT

RXNT

  • Running entire medical practices from single integrated platformnot Annalise.ai
  • Managing electronic prescriptions including controlled Schedule II-V drugsnot Annalise.ai
  • Streamlining billing and claims management with unlimited claim processingnot Annalise.ai
  • Supporting specialty workflows for mental health and hospice providersnot Annalise.ai
  • Capturing appointment reminders and patient billing through patient portalnot Annalise.ai

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Annalise.ai

  • The United States cleared indication covers roughly ten findings for triage and notification, far fewer than the model reports, so a buyer who evaluates the full multi-finding output and then contracts in the United States gets a much narrower cleared use.
  • Triage AI reprioritises a worklist but does not change clinical decisions on its own, so departments that do not redesign how urgent studies are picked up see no measurable improvement in time to treatment.
  • Published validation is largely reader study evidence on detection of individual findings; prospective evidence of shorter time to treatment in routine emergency care is thin.
  • The Annalise brand is being migrated under the Harrison.ai name for the critical care offering, which creates ambiguity in multi-year contracts about what product name is actually being supported.
  • A high finding count raises the alert burden, and departments report that low prevalence findings generate false positives that erode radiologist trust unless the alerting thresholds are tuned locally.

RXNT

  • Specific pricing tiers not displayed; plans reference starting at $118/month
  • E-prescribing only available with yearly subscription
  • Requires contacting sales for personalized pricing

Pricing, plan by plan

Annalise.ai

On request
  • Annalise Enterprise$undefined/year
    • Priced per study analysed or as an annual volume subscription
    • CXR and CTB licensed separately
    • Cleared finding set differs by market, which changes what you are buying

RXNT

On request

No published plan breakdown. See the RXNT review.

Which should you pick?

Choose Annalise.ai if

  • You need annalise enterprise cxr.
  • You work on Web, Cloud, On-premise.
  • You also want annalise enterprise ctb.

Choose RXNT if

Nothing in the data separates RXNT from Annalise.ai on the points above - pick on price and on how each one feels to use.

Questions people ask

Is Annalise.ai or RXNT better?
Neither clearly leads. Annalise.ai starts at On request and RXNT at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Annalise.ai or RXNT?
Annalise.ai starts at On request and RXNT at On request.
Does Annalise.ai or RXNT run on more platforms?
Annalise.ai runs on Web, Cloud, On-premise. RXNT runs on Web.
What is Annalise.ai best used for?
Annalise.ai is most often used for an emergency department wanting pneumothorax and intracranial haemorrhage pushed to the front of the reading queue overnight when cover is thinnest, a teleradiology provider covering many small hospitals that needs consistent triage before a human reads, a screening programme in europe where the broader ce marked decision support indication, rather than the narrow united states triage clearance, is what is being deployed, a radiology department building an ai governance programme that wants one vendor covering both chest radiograph and head ct rather than contracting two separate algorithm suppliers. Of those, an emergency department wanting pneumothorax and intracranial haemorrhage pushed to the front of the reading queue overnight when cover is thinnest and a teleradiology provider covering many small hospitals that needs consistent triage before a human reads are not what RXNT is typically brought in for.
What can Annalise.ai do that RXNT cannot?
Annalise.ai covers Annalise Enterprise CXR, Annalise Enterprise CTB, Triage and notification, Worklist reprioritisation.

Answered from the vendors’ own pages

Annalise.ai: How many findings are FDA cleared?

Around ten across chest X-ray and head CT, for triage and notification only. The model reports far more findings than that; the rest are not cleared in the United States.

RXNT: What is RXNT's pricing model?

RXNT offers a-la-carte and bundled subscription options with monthly or annual billing. Annual subscriptions receive a 10% discount. Pricing starts at $118/month, though specific tier pricing is not displayed.

Source
Annalise.ai: Is the European position different?

Yes. CE marking under the medical device regulation covers a broader decision support indication than the United States triage and notification clearances, so the same software is a different regulatory product depending on where you deploy it.

RXNT: What are the additional costs for RXNT?

RXNT charges $85 per year for EPCS (Electronic Prescribing of Controlled Substances) including ID proofing and biometric authentication. Non-prescribing staff also have license fees, and data imports and extended onboarding are available at additional cost.

Source
Annalise.ai: Does it diagnose?

No. In the United States it is a triage and notification device: it flags studies for earlier review, and the radiologist makes the diagnosis.

RXNT: What onboarding support does RXNT provide?

RXNT includes 45 days of onboarding with the EHR Bundle and 60 days with the Practice Management and Full Suite bundles.

Source
Annalise.ai: Is Annalise.ai becoming Harrison.ai?

The critical care offering is now marketed under the Harrison.ai name. Ask the vendor to name the contracted product explicitly before signing a multi-year deal.

Share

Related pages

Other head to heads